Reported Q: Q1 2026 Rev YoY: N/A EPS YoY: +42.1% Move: -0.95%
HeartSciences Inc
HSCS
$3.13 -0.95%
Exchange NASDAQ Sector Healthcare Industry Medical Devices
Q1 2026
Published: Sep 11, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for HSCS

Reported

Report Date

Sep 11, 2025

Quarter Q1 2026

Revenue

1.90M

YoY: N/A

EPS

-1.58

YoY: +42.1%

Market Move

-0.95%

Previous quarter: Q3 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $1.90M up 0% year-over-year
  • EPS of $-1.58 increased by 42.1% from previous year
  • Gross margin of 60.0%
  • Net income of -2.05M
  • "N/A" - N/A
HSCS
Company HSCS

Executive Summary

HeartSciences Inc (HSCS) reported QQ1 2026 results with modest revenue of USD 1.9 million, producing a gross profit of USD 1.14 million and a robust gross margin of 60.0%. However, the quarter was dominated by extraordinary research and development expenditure (USD 997.206 million) and substantial selling, general, and administrative spending (USD 878.053 million), which together drove operating expenses to USD 1.875 billion and yielded a substantial operating loss. Net income for the period stood at USD -2.055 million, with an EPS of USD -1.58, underscoring a pronounced burn driven by pre-commercial investment in AI-enabled ECG technology and cloud-based platforms.

Key Performance Indicators

Revenue
Stable
1.90M
QoQ: N/A | YoY: N/A
Gross Profit
Increasing
1.14M
60.00% margin
QoQ: N/A | YoY: 12 489.96%
Operating Income
Decreasing
-1.87B
QoQ: 20.97% | YoY: -99 598.32%
Net Income
Decreasing
-2.05M
QoQ: 99.92% | YoY: -11.31%
EPS
Increasing
-1.58
QoQ: 99.94% | YoY: 42.12%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 1.90 -1.58 +0.0% View
Q3 2025 0.00 -2,572.16 +0.0% View
Q2 2025 0.00 -2.27 +0.0% View
Q1 2025 0.00 -2.64 +0.0% View
Q4 2024 0.00 -2.73 +0.0% View